Annual Accounts Payable
$1.60 M
-$2.15 M-57.28%
31 December 2023
Summary:
Barinthus Biotherapeutics annual accounts payable is currently $1.60 million, with the most recent change of -$2.15 million (-57.28%) on 31 December 2023. During the last 3 years, it has fallen by -$3.07 million (-65.70%). BRNS annual accounts payable is now -65.70% below its all-time high of $4.67 million, reached on 01 December 2020.BRNS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$3.08 M
+$520.00 K+20.34%
30 September 2024
Summary:
Barinthus Biotherapeutics quarterly accounts payable is currently $3.08 million, with the most recent change of +$520.00 thousand (+20.34%) on 30 September 2024. Over the past year, it has dropped by -$2.07 million (-40.21%). BRNS quarterly accounts payable is now -40.21% below its all-time high of $5.14 million, reached on 30 September 2023.BRNS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.3% | -40.2% |
| 3 y3 years | -65.7% | +130.1% |
| 5 y5 years | - | - |
BRNS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.7% | at low | -40.2% | +164.7% |
| 5 y | 5 years | -65.7% | at low | -40.2% | +164.7% |
| alltime | all time | -65.7% | at low | -40.2% | +164.7% |
Barinthus Biotherapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.08 M(+20.3%) |
| June 2024 | - | $2.56 M(+120.0%) |
| Mar 2024 | - | $1.16 M(-27.4%) |
| Dec 2023 | $1.60 M(-57.3%) | $1.60 M(-68.9%) |
| Sept 2023 | - | $5.14 M(+111.8%) |
| June 2023 | - | $2.43 M(-43.9%) |
| Mar 2023 | - | $4.33 M(+15.4%) |
| Dec 2022 | $3.75 M | $3.75 M(+55.5%) |
| Sept 2022 | - | $2.41 M(-46.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $4.47 M(-4.0%) |
| Mar 2022 | - | $4.66 M(+92.6%) |
| Dec 2021 | $2.42 M(-48.2%) | - |
| Dec 2021 | - | $2.42 M(+80.9%) |
| Sept 2021 | - | $1.34 M(-71.4%) |
| June 2021 | - | $4.68 M(-3.1%) |
| Mar 2021 | - | $4.83 M(+3.6%) |
| Dec 2020 | $4.67 M(+20.0%) | $4.67 M |
| Dec 2019 | $3.89 M | - |
FAQ
- What is Barinthus Biotherapeutics annual accounts payable?
- What is the all time high annual accounts payable for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual accounts payable year-on-year change?
- What is Barinthus Biotherapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly accounts payable year-on-year change?
What is Barinthus Biotherapeutics annual accounts payable?
The current annual accounts payable of BRNS is $1.60 M
What is the all time high annual accounts payable for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual accounts payable is $4.67 M
What is Barinthus Biotherapeutics annual accounts payable year-on-year change?
Over the past year, BRNS annual accounts payable has changed by -$2.15 M (-57.28%)
What is Barinthus Biotherapeutics quarterly accounts payable?
The current quarterly accounts payable of BRNS is $3.08 M
What is the all time high quarterly accounts payable for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly accounts payable is $5.14 M
What is Barinthus Biotherapeutics quarterly accounts payable year-on-year change?
Over the past year, BRNS quarterly accounts payable has changed by -$2.07 M (-40.21%)